Skip to Content

Menotropins Disease Interactions

There are 6 disease interactions with menotropins:

Major

Gonadotropins (Includes Menotropins) ↔ Thromboembolism

Severe Potential Hazard, Moderate plausibility

Applies to: History - Thrombotic/Thromboembolic Disorder, Thrombotic/Thromboembolic Disorder, Obesity

Thromboembolic events, including venous thrombophlebitis, pulmonary embolism, pulmonary infarction, cerebrovascular occlusion (stroke), and arterial occlusion resulting in loss of limb, have been reported during administration of gonadotropin therapy, both in association with and independent of the Ovarian Hyperstimulation Syndrome. Therapy with gonadotropins should be administered cautiously to patients with or predisposed to thromboembolism.

References

  1. "Product Information. Humegon (menotropins)." Organon, West Orange, NJ.
Major

Menotropins (Includes Menotropins) ↔ Uncontrolled Non- Gonadal Endocrinopathies

Severe Potential Hazard, High plausibility

Applies to: Adrenal Insufficiency, Hyperadrenocorticism, Adrenal Tumor, Hyperaldosteronism, Thyroid Disease, Panhypopituitarism

The use of menotropins is contraindicated in patients with uncontrolled non- gonadal endocrinopathies such as thyroid, adrenal or pituitary disorders.

References

  1. "Product Information. Humegon (menotropins)." Organon, West Orange, NJ.
Major

Menotropins (Includes Menotropins) ↔ Cns Tumors

Severe Potential Hazard, High plausibility

Applies to: Pituitary Tumor, Brain/Intracranial Tumor

The use of menotropins is contraindicated in patients with CNS lesions, such as pituitary gland or hypothalamus tumors. Menotropins possess LH and FSH activity.

References

  1. "Product Information. Humegon (menotropins)." Organon, West Orange, NJ.
Major

Menotropins (Includes Menotropins) ↔ Vaginal Bleeding And Reproductive Organ Tumors

Severe Potential Hazard, High plausibility

Applies to: Abnormal Uterine Bleeding, Endometrial Dysplasia, Neoplasia -- Estrogen Dependent

The use of menotropins is contraindicated in female patients with abnormal vaginal bleeding of undetermined origin. Patients should be evaluated to ensure neoplastic lesions are not present. The use of menotropins is contraindicated in the presence of sex hormone dependent tumors of the reproductive tract or accessory organs.

References

  1. "Product Information. Humegon (menotropins)." Organon, West Orange, NJ.
Moderate

Gonadotropins (Includes Menotropins) ↔ Pulmonary Conditions

Moderate Potential Hazard, Moderate plausibility

Applies to: Pulmonary Impairment

Serious pulmonary conditions such as atelectasis, acute respiratory syndrome, and exacerbation of asthma have been reported in women treated with gonadotropins. Caution and monitoring is advised if used in women with pulmonary conditions.

Moderate

Menotropins (Includes Menotropins) ↔ Renal/Hepatic

Moderate Potential Hazard, Moderate plausibility

Applies to: Renal Dysfunction, Liver Disease

Safety, efficacy and pharmacokinetics of menotropins have not been established in women with renal or hepatic insufficiency. Caution is advised.

menotropins drug Interactions

There are 2 drug interactions with menotropins

menotropins alcohol/food Interactions

There is 1 alcohol/food interaction with menotropins

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2018 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide